Prospective Study of Palonosetron in the Prophylaxis/Rescue of Radiation Induced Nausea and Vomiting (RINV) - a Phase II Study
Phase of Trial: Phase II
Latest Information Update: 27 Apr 2017
At a glance
- Drugs Palonosetron (Primary)
- Indications Chemotherapy-induced nausea and vomiting
- Focus Therapeutic Use
- 24 Apr 2017 Planned primary completion date changed from 1 Mar 2017 to 1 Aug 2017.
- 14 Apr 2016 Planned primary completion date changed from 1 Mar 2016 to 1 Mar 2017.
- 19 Apr 2015 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov record.